Hyperhomocysteinaemia and vascular access thrombosis among chronic hemodialysis patients in Taiwan: A retrospective study

International Journal of Clinical Practice

Volumn 60, Issue 12, 2006, Pages 1596-1599

  Chen, T C ^a   Wang, I K ^a   Lee, C H ^a   Chang, H W ^b   Chiou, T T Y ^a   Lee, C T ^a   Fang, J T ^a   Wu, M S ^a   Hsu, K T ^a   Yang, C C ^a   Wang, P H ^b   Chuang, Feng Rong ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

Author keywords

End stage renal disease; Haemodialysis; Hyperhomocysteinaemia; Vascular access thrombosis

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; PYRIDOXINE; RIBOFLAVIN; THIAMINE; VITAMIN B COMPLEX;

ADULT; AGED; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEMODIALYSIS; HUMAN; HYPERHOMOCYSTEINEMIA; INCIDENCE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; SHUNT THROMBOSIS; STATISTICAL SIGNIFICANCE; TAIWAN; VASCULAR ACCESS DEVICE; VITAMIN BLOOD LEVEL;

AGED; CASE-CONTROL STUDIES; CATHETERS, INDWELLING; FEMALE; GRAFT OCCLUSION, VASCULAR; HUMANS; HYPERHOMOCYSTEINEMIA; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; THROMBOSIS;

EID: 33750971727     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2006.00848.x     Document Type: Article

References (20)

1. Fermo I, Dangelo SV, Paroni R et al. Prevalence of moderate hyperhomocysteinemia in patients with early-onset venous and arterial occlusive disease. Ann Intern Med 1995; 23: 747-53.
2. Den Heijer M, Blom HJ, Gerrits WBJ et al. Is hyperhomocysteinemia a risk factor for recurrent venous thrombosis? Lancet 1995; 345: 882-5.
3. Tamura T, Bergman SM, Morgan SL. Homocysteine, B vitamins, and vascular-access thrombosis in patients treated with hemodialysis. Am J Kidney Dis 1998; 32: 475-81.
4. Bowden RG, Wyatt FB, Wilson R. Homocysteine and vascular access thrombosis in end-stage renal disease patients: A retrospective study. J Nephrol 2002; 15: 666-70.
5. Hojs R, Gorenjak M, Ekart R et al. Homocysteine and vascular access thrombosis in hemodialysis patients. Ren Fail 2002; 24: 215-22.
6. Sirrs S, Ganz G, Nussbaumer G et al. Hyperhomocysteinemia and levels of lipoprotein(A) are inversely related to vascular access failure in hemodialysis patients. Clin Invest Med 1997; 20: S68 (Abstract).
7. Ducloux D, Pascal B, Jamali M et al. Is hyperhomocysteinemia a risk factor for recurrent vascular access thrombosis in hemodialysis patients? Nephrol Dial Transplant 1997; 12: 2037-8.
8. Woods JD, Turenne MN, Strawderman RL et al. Vascular access survival among incident hemodialysis patients in the United State. Am J Kidney Dis 1997; 30: 50-7.
9. Bergman S, Tamura T, Morgan S. Homocysteine and 5,10methylenetetrahydrofolate reductase genotypes in patients with recurrent arteriovenous graft thrombosis. J Am Soc Nephrol 1997; 8: 153A (Abstract).
10. Moustapha A, Gupta A, Robinson K et al. Prevalence and determinants of hyperhomocysteinemia in hemodialysis and peritoneal dialysis. Kidney Int 1999; 55: 1470-5.
11. Manns BJ, Burgess ED, Parsons HG et al. Hyperhomocysteinemia, anticardiolipin antibody status, and risk for vascular access thrombosis in hemodialysis patients. Kidney Int 1999; 55: 315-20.
12. Feldman HI, Kobrin S, Wasserstein A. Hemodialysis vascular access morbidity. J Am Soc Nephrol 1996; 7: 523-35.
13. Churchill DN, Taylor DW, Cook RJ et al. Canadian Hemodialysis morbidity study. Am J Kidney Dis 1992; 19: 214-34.
14. Prischl FC, Kirchgatterer A, Brandstatter E et al. Parameters of prognostic relevance to the patency of vascular access in hemodialysis patients. J Am Soc Nephrol 1995; 6: 1613-8.
15. Chazan JA, London MR, Pono LM. Long-term survival of vascular accesses in a large chronic hemodialysis population. Nephron 1995; 69: 228-33.
16. Javob RA, Wu MM, Henning SM et al. Homocysteine increases as folate decreases in plasma of healthy men during short-term dietary folate and methyl group restriction. J Nutr 1994; 124: 1072-80.
17. Ubbink JB, Hayward VWJ, van der Merwe A et al. Vitamin B 12, vitaminB 6, and folate nutritional status in men with hyperhomocysteinemia. Am J Clin Nutr 1993; 57: 47-53.
18. Libetta C, Zucchi M, Gori E et al. Prevalence of hyperhomocysteinemia in male hemodialysis patients. Kidney Int 2003; 64: 1531 (Letter).
19. Windus DW, Jendrisak MD, Delmez JA. Prosthetic fistula survival and complications in hemodialysis patients: Effect of diabetes and age. Am J Kidney Dis 1992; 19: 448-52.
20. Palder SB, Kirkman RL, Whittemore AD et al. Vascular access for hemodialysis. Patency rates and results of revision. Ann Surg 1985; 202: 235-9.